Authority: Supreme Court of India
Order Date: 14-08-2026
Case Overview
- Petition for Special Leave to Appeal (C) No. 23021/2026 filed by Cipla Limited against National Pharmaceutical Pricing Authority & others, arising from the Bombay High Court’s final judgment and order dated 24‑04‑2026 in WP No. 2069/2022.
- The petition seeks admission of IA No. 193017/2026 for permission to file additional documents, facts, and annexures.
- Counsel for the petitioner included senior advocates S. Niranjan Reddy, Bindi Girish Dave, Aman Raj Gandhi, Aayesh Gandhi, Parthasarathy Bose, Dhairyah C. Shroff, and Palak Arora. Respondents were represented by Additional Solicitor General (Mr. Anil Kaushik) and a team of advocates.
Court Order
- The Court granted the respondent’s Additional Solicitor General a period of four weeks to file a counter‑affidavit.
- The matter was listed for further hearing on 18‑09‑2026.
- An interim order was issued to continue the proceedings pending the filing of the counter‑affidavit.
Final Outcome
- The extension of four weeks to the respondent is approved, and the case will proceed on the scheduled date of 18‑09‑2026.
Topics: Pharmaceutical Pricing, Court Procedure